The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued positive opinions for two biosimilars that could expand access for clinicians treating retinal ...

The mom of three shared the card on the Friday, Dec. 12 episode of 'Today with Jenna & Friends' Jenna Bush Hager/instagram Jenna Bush Hager is sharing her family's holiday card The mom of three's card ...

The U.S. Securities and Exchange Commission (SEC) implicitly granted approval for some stocks and other securities to be tokenized and traded on blockchains. The Depository Trust & Clearing Corp.

UNESCO panel has recommended Italian cuisine for heritage list Recognition could boost tourism in Italy Bid celebrates how sharing meals strengthens community ties Critics say UNESCO bid is a ...

Demon Slayer: Infinity Castle The Movie has been nominated at the 2026 Golden Globe Awards. The announcement was made on December 8, 2025, by Marlon Wayans. While the Infinity Castle movie is the ...

The Golden Globes' box office category this year includes a film that hasn't grossed a single cent at the box office – at least, not yet. But many were confused to see the "Avatar" sequel in a ...

The first full-length book by Pope Leo XIV to come out in the U.S. will be published next year. HarperOne said Wednesday that it acquired world rights to Peace Be with You! My Words to the Church and ...

The shoes both also feature the team’s iconic English D logo on the heel. An homage to Booker’s Mitten home state, the Low x Book will cost $135 a pair. We expect the stone-washed, cracked leather ...

SPOILER ALERT: This story discusses major plot points, including the ending and the post-credits scenes, for “Zootopia 2,” currently playing in theaters. “Zootopia’s” rookie cops Judy Hopps (voiced by ...

A religious school in England is currently making headlines for banning its students from singing the original songs from Netflix‘s animated blockbuster “KPop Demon Hunters.” As reported by the BBC, ...

As Roche works to switch certain patients with breast cancer over to a fixed-dose combination of two medicines, its 13-year-old drug Perjeta is inching toward the end of its exclusive run in the U.S.

French developer Don't Nod has reported its revenue multiplied to €7 million during the first half of 2025, compared to €1.8 million during the same period last year. The developer attributed this ...